Key Points Multicancer screening technologies are advancing rapidly. Grail is one of the leaders in the cancer screening space. 10 stocks we like better than Grail › Despite decades of progress in fighting it, cancer remains deadly. It is the second-leading cause of death in the United States, behind only heart disease. Early detection and screening are two of the most powerful tools against the disease -- they lead to higher survival rates, less invasive treatments, fewer side effects, and a high ...